Literature DB >> 23798514

The effects of Capn1 gene inactivation on skeletal muscle growth, development, and atrophy, and the compensatory role of other proteolytic systems.

C M Kemp1, W T Oliver, T L Wheeler, A H Chishti, M Koohmaraie.   

Abstract

Myofibrillar protein turnover is a key component of muscle growth and degeneration, requiring proteolytic enzymes to degrade the skeletal muscle proteins. The objective of this study was to investigate the role of the calpain proteolytic system in muscle growth development using μ-calpain knockout (KO) mice in comparison with control wild-type (WT) mice, and evaluate the subsequent effects of silencing this gene on other proteolytic systems. No differences in muscle development between genotypes were observed during the early stages of growth due to the up regulation of other proteolytic systems. The KO mice showed significantly greater m-calpain protein abundance (P < 0.01) and activity (P < 0.001), and greater caspase 3/7 activity (P < 0.05). At 30 wk of age, KO mice showed increased protein:DNA (P < 0.05) and RNA:DNA ratios (P < 0.01), greater protein content (P < 0.01) at the expense of lipid deposition (P < 0.05), and an increase in size and number of fast-twitch glycolytic muscle fibers (P < 0.05), suggesting that KO mice exhibit an increased capacity to accumulate and maintain protein in their skeletal muscle. Also, expression of proteins associated with muscle regeneration (neural cell adhesion molecule and myoD) were both reduced in the mature KO mice (P < 0.05 and P < 0.01, respectively), indicating less muscle regeneration and, therefore, less muscle damage. These findings indicate the concerted action of proteolytic systems to ensure muscle protein homeostasis in vivo. Furthermore, these data contribute to the existing evidence of the importance of the calpain system's involvement in muscle growth, development, and atrophy. Collectively, these data suggest that there are opportunities to target the calpain system to promote the growth and/or restoration of skeletal muscle mass.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23798514      PMCID: PMC3962768          DOI: 10.2527/jas.2012-5737

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  42 in total

Review 1.  The molecular regulation of myogenesis.

Authors:  L A Sabourin; M A Rudnicki
Journal:  Clin Genet       Date:  2000-01       Impact factor: 4.438

Review 2.  Transitions of muscle fiber phenotypic profiles.

Authors:  D Pette; R S Staron
Journal:  Histochem Cell Biol       Date:  2001-05       Impact factor: 4.304

3.  Effect of postmortem storage on mu-calpain and m-calpain in ovine skeletal muscle.

Authors:  E Veiseth; S D Shackelford; T L Wheeler; M Koohmaraie
Journal:  J Anim Sci       Date:  2001-06       Impact factor: 3.159

Review 4.  Calpain and caspase: can you tell the difference?

Authors:  K K Wang
Journal:  Trends Neurosci       Date:  2000-01       Impact factor: 13.837

5.  Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition.

Authors:  M A Badalamente; A Stracher
Journal:  Muscle Nerve       Date:  2000-01       Impact factor: 3.217

6.  A BODIPY fluorescent microplate assay for measuring activity of calpains and other proteases.

Authors:  V F Thompson; S Saldaña; J Cong; D E Goll
Journal:  Anal Biochem       Date:  2000-03-15       Impact factor: 3.365

7.  Disruption of the mouse mu-calpain gene reveals an essential role in platelet function.

Authors:  M Azam; S S Andrabi; K E Sahr; L Kamath; A Kuliopulos; A H Chishti
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

8.  Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.

Authors:  L D Klaman; O Boss; O D Peroni; J K Kim; J L Martino; J M Zabolotny; N Moghal; M Lubkin; Y B Kim; A H Sharpe; A Stricker-Krongrad; G I Shulman; B G Neel; B B Kahn
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases.

Authors:  B T Chua; K Guo; P Li
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

10.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.

Authors:  Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

View more
  3 in total

1.  Reduced skeletal muscle fiber size following caloric restriction is associated with calpain-mediated proteolysis and attenuation of IGF-1 signaling.

Authors:  Yue Lu; Jennifer S Bradley; Sarah R McCoski; John M Gonzalez; Alan D Ealy; Sally E Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-22       Impact factor: 3.619

2.  GSK3-β promotes calpain-1-mediated desmin filament depolymerization and myofibril loss in atrophy.

Authors:  Dina Aweida; Inga Rudesky; Alexandra Volodin; Eitan Shimko; Shenhav Cohen
Journal:  J Cell Biol       Date:  2018-07-30       Impact factor: 10.539

3.  Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men.

Authors:  Nima Gharahdaghi; Supreeth Rudrappa; Matthew S Brook; Iskandar Idris; Hannah Crossland; Claire Hamrock; Muhammad Hariz Abdul Aziz; Fawzi Kadi; Janelle Tarum; Paul L Greenhaff; Dumitru Constantin-Teodosiu; Jessica Cegielski; Bethan E Phillips; Daniel J Wilkinson; Nathaniel J Szewczyk; Kenneth Smith; Philip J Atherton
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-09-30       Impact factor: 12.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.